More articles from editorial

You have access
A way forward for research on biomarkers for psychiatric disorders
Patricia Boksa

J Psychiatry Neurosci March 01, 2013 38 (2) 75-77; DOI: https://doi.org/10.1503/jpn.130018
You have access
What does it mean to have enough evidence?
Glenda MacQueen

J Psychiatry Neurosci January 01, 2013 38 (1) 3-5; DOI: https://doi.org/10.1503/jpn.120240
You have access
Loose ends of psychiatric research
Martin Alda and Tomas Hajek

J Psychiatry Neurosci November 01, 2012 37 (6) 367-368; DOI: https://doi.org/10.1503/jpn.120192
You have access
Drugs for kids: Good or bad?
Paul R. Albert

J Psychiatry Neurosci September 01, 2012 37 (5) 293-295; DOI: https://doi.org/10.1503/jpn.120140
You have access
Illness comorbidity as a biomarker?
Hymie Anisman and Shawn Hayley

J Psychiatry Neurosci July 01, 2012 37 (4) 221-223; DOI: https://doi.org/10.1503/jpn.120092
You have access
Publication bias: What are the challenges and can they be overcome?
Ridha Joober, Norbert Schmitz, Lawrence Annable and Patricia Boksa

J Psychiatry Neurosci May 01, 2012 37 (3) 149-152; DOI: https://doi.org/10.1503/jpn.120065
You have access
Abnormal synaptic pruning in schizophrenia: Urban myth or reality?
Patricia Boksa

J Psychiatry Neurosci March 01, 2012 37 (2) 75-77; DOI: https://doi.org/10.1503/jpn.120007
You have access
Psychiatry’s age of enlightenment: optogenetics and the discovery of novel targets for the treatment of psychiatric disorders
Michelle M. Sidor

J Psychiatry Neurosci January 01, 2012 37 (1) 4-6; DOI: https://doi.org/10.1503/jpn.110175
You have access
What is a functional genetic polymorphism? Defining classes of functionality
Paul R. Albert

J Psychiatry Neurosci November 01, 2011 36 (6) 363-365; DOI: https://doi.org/10.1503/jpn.110137
You have access
Inflaming depression
Hymie Anisman

J Psychiatry Neurosci September 01, 2011 36 (5) 291-295; DOI: https://doi.org/10.1503/jpn.110071

Main menu

User menu

Search

More articles from editorial

Pages

Content

Authors & Reviewers

About